Brd4 is an atypical kinase that regulates transcription
$525,070ZIAFY2011CANIH
Division Of Basic Sciences - Nci
Investigators
Linked publications, trials & patents
Paper 36378541Paper 32482868Paper 27450555Paper 27058666Paper 26504077Paper 23131666Paper 23027873Paper 22509028
Abstract
Brd4, a bromodomain protein that contributes to the regulation of transcription initiation and elongation, has been implicated in regulation of both primary and metastatic tumor growth. However, the molecular mechanism(s) of Brd4 function remains unknown. Since Brd4 binds acetylated histones in chromatin, it has been presumed that it functions to recruit a critical transcriptional regulator (PTEFb) to promoters. We now identify Brd4 as a Pol II CTD Ser2 kinase that phosphorylates the CTD of Pol II independent of other CTD kinases, both in vitro and in vivo, providing a novel function for this tumor regulatory protein, which fundamentally alters our understanding of its mechanism of action.
View original record on NIH RePORTER →